General Practice Doctors in Powell, OH Accepting Medicare

2 General Practice doctors found. Showing 1 - 2

Damon M Whitfield, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 10208 Sawmill Pkwy, Powell, OH 43065 Phone: 614-792-2779    Fax: 614-792-7255

Gary Francis Leanz, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 396 Shale Ridge Ct, Powell, OH 43065 Phone: 614-436-2639

News Archive

Toddlers affected most by secondhand smoke exposure at home

Secondhand smoke in the home appears to induce markers for heart disease as early as the toddler years, researchers reported at the American Heart Association's 48th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.

SMArt platform to support flexible health IT environment, promote innovation

Through a grant from the Office of the National Coordinator for Health Information Technology, researchers at Children's Hospital Boston and Harvard Medical School have developed a first-of-its kind platform architecture to support a flexible health information technology environment and promote innovation.

Researchers develop new method to identify genes involved in kidney diseases

Understanding how genes act in specific tissues is critical to our ability to combat many human diseases, from heart disease to kidney failure to cancer. Yet isolating individual cell types for study is impossible for most human tissues.

Research shows split liver transplantation carries no increased risk of failure in either recipient

Split liver transplantation carries no increased risk of failure in either recipient, allowing surgeons to safely save two lives from a single donated organ (graft), according to new research from Boston Children's Hospital published online in the Journal of the American College of Surgeons.

FDA grants orphan drug designation to ImmunoGen's lorvotuzumab mertansine for small-cell lung cancer

ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC).

Read more Medical News

› Verified 6 days ago